Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/- for Moneycontrol Pro subscribers. Price Increasing Soon!
you are here: HomeNewscoronavirus

COVID-19 Vaccine | Covaxin production to be increased to 6-7 crore doses a month in July-August: Health Ministry

The production capacity of the vaccine being manufactured by Bharat Biotech is expected to reach nearly 10 crore doses a month by September.

May 31, 2021 / 09:03 PM IST
To further increase the COVID-19 vaccine manufacturing capacity, Bharat Biotech had said it partnered with IIL to make the drug substance for Covaxin. (Representative image)

To further increase the COVID-19 vaccine manufacturing capacity, Bharat Biotech had said it partnered with IIL to make the drug substance for Covaxin. (Representative image)

The monthly production of indigenously developed coronavirus vaccine Covaxin will be increased to 6-7 crore doses in July-August from one crore doses in April, the Union Health Ministry said on Friday. The production capacity of the vaccine being manufactured by Bharat Biotech is expected to reach nearly 10 crore doses a month by September, the ministry said.

"There have been some unfound media reports on unaccounted vaccine doses of Bharat Biotech. These reports are incorrect and are not supported by full information on the matter. The claims of Bharat Biotech having 6 crore doses is an error of comprehension among some quarters reporting the said matter," the ministry said in its statement. The production capacity of Covaxin will be doubled by May-June and then increased nearly six-seven fold by July-August 2021, i.e. increasing the production from 1 crore vaccine doses in April to 6-7 crore vaccine doses/month in July- August.

COVID-19 vaccine mix and match trial to begin in few weeks: Dr NK Arora

"It is expected to reach nearly 10 crore doses per month by September 2021," the statement said. This capacity augmentation of Covaxin carried out under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India and implemented by the Department of Biotechnology to accelerate the development and production of indigenous jabs.

Vaccine being a biological product of medical importance takes time for harvesting and quality testing, the ministry said, highlighting, "this cannot be done overnight to ensure a safe product. Thus increase in capacity of manufacturing too needs to be a guided process and an increase in gross production does not translate to immediate supply." According to data compiled in the morning of May 28, Bharat Biotech has supplied 2,76,66,860 vaccine doses to the Government of India. Out of these, 2,20,89,880 doses, including wastage, have been consumed by states and union territories.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
With this, the balance available doses of vaccines with states and UTs are 55,76,980 doses, the statement said. Private hospitals have also received 13,65,760 doses of Covaxin in the same month over and above what has been supplied to the Government of India and the states. "In May, additional 21,54,440 doses of Covaxin are to be supplied. This takes the total vaccine supplied and in pipeline till date to 3,11,87,060 doses. Almost 90,00,000 doses are committed for the month of June by the manufacturer," the statement stated.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

PTI
first published: May 31, 2021 09:03 pm
Sections
ISO 27001 - BSI Assurance Mark